Skip to main content
Bavarian Nordic logo

Bavarian Nordic — Investor Relations & Filings

Ticker · BAVA ISIN · DK0015998017 LEI · 2138006JCDVYIN6INP51 CO Manufacturing
Open in API
Filings indexed 2,297 across all filing types
Latest filing 2025-10-16 M&A Activity
Country DK Denmark
Listing CO BAVA

About Bavarian Nordic

https://www.bavarian-nordic.com/

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Recent filings

Filing Released Lang Actions
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a 'Supplementary Statement' issued by the Board of Directors of Bavarian Nordic A/S in response to an increased takeover offer price from Innosera ApS. It details the board's assessment of the revised offer, reiterates their recommendation to shareholders, and provides updated financial context regarding the takeover bid. This falls under the category of M&A activity, specifically documents related to takeover bids and board responses to such offers.
2025-10-16 English
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a company announcement regarding a takeover offer for Bavarian Nordic. It explicitly states that the Board of Directors is publishing a 'Supplementary Statement' in response to an improved takeover offer. While the document mentions that the Supplementary Statement is attached, the document itself serves as the official announcement of this board recommendation and the publication of the statement. According to the 'Menu vs Meal' rule, since this is a short announcement (4 pages) that introduces and provides links/references to the actual report (the Supplementary Board Statement), it is classified as a Report Publication Announcement (RPA).
2025-10-16 English
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a 'Supplementary Statement' (Supplerende Redegørelse) issued by the Board of Directors of Bavarian Nordic A/S regarding a voluntary public takeover offer. It details an increase in the offer price from DKK 233 to DKK 250 per share. This document is a formal response to a takeover bid, which falls under the category of M&A activity (takeover bids/merger proposals).
2025-10-16 Danish
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a 'Supplementary Statement' issued by the Board of Directors of Bavarian Nordic A/S in response to an increased takeover offer price from Innosera ApS. It details the board's assessment of the revised offer, reiterates their recommendation to shareholders, and provides updated financial context regarding the takeover bid. This falls under the category of M&A activity, specifically documents related to takeover bids and board responses to such offers.
2025-10-16 English
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a formal corporate announcement from Bavarian Nordic A/S regarding a 'Supplementary Statement' (Supplerende Redegørelse) from the Board of Directors in response to a voluntary public takeover offer. It details the board's recommendation to shareholders, references previous offer documents, and provides contact information for investor relations. While it discusses a takeover, it is not the merger agreement itself but rather the board's formal response/statement regarding the offer, which falls under the category of M&A activity announcements (TAR) as it pertains to the ongoing takeover bid process.
2025-10-16 Danish
M&A Activity 2025
M&A Activity Classification · 100% confidence The document is a 'Supplementary Statement' (Supplerende Redegørelse) issued by the Board of Directors of Bavarian Nordic A/S regarding a voluntary public takeover offer. It details an increase in the offer price from DKK 233 to DKK 250 per share. This document is a formal response to a takeover bid, which falls under the category of M&A activity (takeover bids/merger proposals).
2025-10-16 Danish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.